ACADIA PHARMACEUTICALS INC — Director's Dealing 2013

Apr 12, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2013-04-11

Reporting Person: Aasen Thomas H (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-04-11	Common Stock	M	7500	$1.08	Acquired	57971	Direct
2013-04-11	Common Stock	M	12500	$2	Acquired	70471	Direct
2013-04-11	Common Stock	M	14029	$1.55	Acquired	84500	Direct
2013-04-11	Common Stock	G	40000	—	Disposed	44500	Direct
2013-04-11	Common Stock	G	40000	—	Acquired	40000	Indirect
2013-04-11	Common Stock	S	40000	$11.06	Disposed	0	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-04-11	Stock Option (right to buy)	$1.08	M	7500	Disposed	2013-09-07	Common Stock (7500)	Direct
2013-04-11	Stock Option (right to buy)	$2	M	12500	Disposed	2014-03-11	Common Stock (12500)	Direct
2013-04-11	Stock Option (right to buy)	$1.55	M	14029	Disposed	2020-03-11	Common Stock (14029)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2011.

F2: Immediately.